Compare JAGX & OLOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JAGX | OLOX |
|---|---|---|
| Founded | 2013 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | RETAIL: Building Materials |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0M | 1.1M |
| IPO Year | 2014 | 2011 |
| Metric | JAGX | OLOX |
|---|---|---|
| Price | $0.40 | $0.60 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 686.5K | ★ 3.0M |
| Earning Date | 11-16-2026 | 11-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 82.42 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,511,000.00 | $2,952,578.00 |
| Revenue This Year | $77.78 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.20 | $0.45 |
| 52 Week High | $41.53 | $219.00 |
| Indicator | JAGX | OLOX |
|---|---|---|
| Relative Strength Index (RSI) | 39.52 | 36.47 |
| Support Level | $0.29 | $0.60 |
| Resistance Level | $0.46 | $1.29 |
| Average True Range (ATR) | 0.12 | 0.05 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 2.13 | 22.59 |
Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
Olenox Industries Inc provides modular structures made from code-engineered cargo shipping containers as permanent or temporary structures for residential housing, commercial structures, and industrial applications. Its segments are: Construction, Software-as-a-Service (SaaS), Oil and Gas, and Others. Construction segment generates maximum revenue and designs and constructs modular structures in its factory using recycled shipping containers; in the past, traditional wood and steel frames were also used. It markets its construction products to contractors, home builders, building owners, other resellers, large multinational corporations, government agencies, private developers, the U.S. Military, individual homeowners, and pop-up retailers across the continental United States and Canada.